MANAGEMENT OF CONGENITAL NEPHROTIC SYNDROME OF THE FINNISH TYPE

被引：148

作者：

HOLMBERG, C

ANTIKAINEN, M

RONNHOLM, K

ALAHOUHALA, M

JALANKO, H

机构：

[1] Division of Paediatric Nephrology, Children's Hospital, University of Helsinki, Helsinki, SF-00290

来源：

PEDIATRIC NEPHROLOGY | 1995年 / 9卷 / 01期

关键词：

NEPHROTIC SYNDROME; CONGENITAL; FINNISH TYPE; THERAPY;

D O I：

10.1007/BF00858984

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Congenital nephrotic syndrome of the Finnish type (CNF) is a rare autosomal recessively inherited disease characterised by intrauterine onset of massive urinary loss of proteins, 90% of which is albumin. The CNF gene has been localised to the long arm of chromosome 19, but the pathogenesis remains unclear. Historically, all CNF patients died, usually within the first 6 months of life. Today, a normal life can be achieved for a child with CNF by correcting the protein deficiency and normalising nutrition. This is accomplished by early intravenous albumin supplementation, nutritional support, aggressive treatment of complications and early renal transplantation, after bilateral nephrectomy and peritoneal dialysis. In the present article current treatment strategies are reviewed, and our own experience with 43 CNF patients during the last 10 years is presented.

引用

页码：87 / 93

页数：7

共 51 条

[11] Huttunen N-P, Congenital nephrotic syndrome of the Finnish type. Study of 75 patients, Arch Dis Child, 51, pp. 344-348, (1976)
[12] Kestila M., Mannikko M., Holmberg C., Gyapay G., Weissenbach J., Savolainen E-R, Peltonen L., Tryggvasson K., Congenital nephrotic syndrome of the Finnish type maps to the long arm of chromosome 19, Am J Hum Genet, 54, pp. 757-764, (1994)
[13] Vernier R.L., Klein D.J., Oegema T.R., Michael A.F., Brown D.M., Heparan sulfate-rich anionic sites in human glomerular basement membrane. Decreased concentration in congenital nephrotic syndrome, N Engl J Med, 309, pp. 1001-1009, (1983)
[14] Vermeylen C., Levin M., Mossman J., Barratt T.M., Glomerular and urinary heparan sulphate in congenital nephrotic syndrome, Pediatr Nephrol, 3, pp. 122-129, (1989)
[15] Mahan J.D., Sisson-Ross S.S., Vernier R.L., Anionic sites in the human kidney: ex vivo perfusion studies, Mol Pathol, 2, pp. 117-124, (1989)
[16] Jadresic L.P., Filler G., Barratt T.M., Urine glycosaminoglycans in congenital and acquired nephrotic syndrome, Kidney Int, 40, pp. 280-284, (1991)
[17] Ljungberg P., Jalanko H., Holmberg C., Holthofer H., Congenital nephrosis of the Finnish type (CNF): matrix components of the glomerular basement membranes and of cultured mesangial cells, Histochem J, 25, pp. 606-612, (1993)
[18] Van den Heuvel L.P.W.J., Van den Born J., Jalanko H., Schroder C.H., Veerkamp J.H., Assmann K.J.M., Berden J.H.M., Holmberg C., Rapola J., Monnens L.A.H., The glycosaminoglycan content of renal basement membranes in the congenital nephrotic syndrome of the Finnish type, Pediatr Nephrol, 6, pp. 10-15, (1992)
[19] Jalanko H., Holmberg C., Ljungberg P., Rapola J., Koskimies O., Holthofer H., Glomerular basement membrane in congenital nephrotic syndrome of the Finnish type, Pediatr Nephrol, 4, (1990)
[20] Ljungberg P., Glycosaminoglycans in urine and amniotic fluid in congenital nephrotic syndrome of the Finnish type, Pediatr Nephrol, 8, pp. 531-536, (1994)

← 1 2 3 4 5 6 →